Products for Research Use Only
RegisterLogin

Lazertinib mesylate

CAT: 0013-GTR19257906-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19257906-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lazertinib (mesylate) (YH25448 (mesylate) ; GNS-1480 (mesylate) ) is an orally active EGFR inhibitor capable of crossing the blood-brain barrier. It suppresses the p-EGFR, p-AKT, and p-ERK signaling pathways, leading to apoptosis. Lazertinib (mesylate) demonstrates antitumor activity in the H1975-luc BM xenograft model in mice and is applicable for researching non-small cell lung cancer.
CAS Number
2247995-37-3
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
O=C (C=C) NC1=CC (NC2=NC=CC (=N2) N3N=C (C=4C=CC=CC4) C (=C3) CN (C) C) =C (OC) C=C1N5CCOCC5.O=S (=O) (O) C
Molecular Formula
C31H38N8O6S
Molecular Weight
650.75
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19188444-01Lazertinib
GTR19162937-01Lazertinib
GTR19250453-01Morphothiadin mesylate
GTR19174945-01Nafamostat mesylate
GTR19174375-01Tirbanibulin Mesylate
GTR19172194-01Apilimod mesylate
GTR19168207-01Safinamide mesylate
GTR19167768-01Ibutamoren Mesylate
GTR19167495-01Alflutinib mesylate
GTR19167330-01Flumatinib mesylate

Alternative Products

CatalogName
HY-109061B-01Lazertinib (mesylate)
T207270-01Lazertinib mesylate
JH920502Lazertinib mesylate monohydrate
B2348-5Lazertinib

Popular Products